Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| HS 2672 | Other Identifier | Uganda National Council of Science and Technology |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study seeks to determine whether workplace delivery of HIV self-testing will lead to an increase in uptake of HIV testing and subsequent linkage to care or prevention services among men in Uganda.
The current coverage of HIV testing and counseling in Uganda is 60% with only 34% of these being men and only about 55% of males living with HIV know their status (MoH, 2016). The challenges with HIV testing require a new focus and new approaches to reach people with undiagnosed HIV infection.
HIV self-testing (HIVST) is one such innovative approach to making testing more accessible to several under-served populations such as men and key populations (WHO, 2013).
In this regard, this study seeks to determine whether providing HIVST in workplace settings will increase the uptake of HIV testing services among men employed in private security services in Uganda and improve linkage to treatment and prevention services.
Design: Cluster randomized trial in two Ugandan districts
Participants: Male employees of private security companies
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Workplace-based HIV Self-Testing | Experimental | i. Explain the procedure of conducting HIVST & interpret HIV self- test result to the user. ii. Demonstrate how to perform the self-test and how to interpret the self-test result. iii. Provide appointment card including information on linkage for HIV prevention services and further testing for diagnosis among those with a reactive self-test. Participants with a non-reactive self-test will be referred to HIV prevention services. iv. Provide a toll free number for continued consultation |
|
| Workplace-based standard HIV Testing Services (HTS) | No Intervention | Standard of care following the HIV testing algorithm . |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Oral HIV Self-Test (OraQuick) | Device | The oral HIV self-test is a device for taking a test which is painless. The user gently swipes the test swab along the upper gums once and the lower gums once. The swab is then inserted inside the test tube provided and results are ready in 20 minutes. |
| Measure | Description | Time Frame |
|---|---|---|
| HIV self-testing | Proportion of men who self-report testing after receiving a kit at the workplace | Within one month of the intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Linkage into HIV care and confirmatory testing following HIV self-testing | Proportion of participants who self report confirmatory testing from a health facility for all participants with a reactive-self test | measured at 1 and 3 months after intervention |
| Consistent condom use following HIV self-testing |
Not provided
Eligibility Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Patience Muwanguzi, PhD | Contact | +256777036811 | pamuwanguzi@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Patience A. Muwanguzi | Makerere University | Principal Investigator |
| Nelson K. Sewankambo | Makerere University | Study Director |
| Noah Kiwanuka |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Security companies | Recruiting | Hoima | Uganda |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 34723826 | Derived | Muwanguzi PA, Ngabirano TD, Kiwanuka N, Nelson LE, Nasuuna EM, Osingada CP, Nabunya R, Nakanjako D, Sewankambo NK. The Effects of Workplace-Based HIV Self-testing on Uptake of Testing and Linkage to HIV Care or Prevention by Men in Uganda (WISe-Men): Protocol for a Cluster Randomized Trial. JMIR Res Protoc. 2021 Nov 1;10(11):e25099. doi: 10.2196/25099. | |
| 33883157 |
| Label | URL |
|---|---|
| The Uganda HIV and AIDS country progress report July 2015-June 2016 | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| D018761 | Multiple Endocrine Neoplasia Type 1 |
| ID | Term |
|---|---|
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D015229 | Sexually Transmitted Diseases, Viral |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Proportion of participants who use a condom for each sexual encounter in a month. |
| measured at 1 and 3 months after intervention |
| Initiation of Antiretroviral Therapy (ART) following a confirmatory HIV test | Proportion of participants who self report ART initiation following a positive result from a confirmatory HIV test result or evidence of an ART card. Data will be collected using a questionnaire. | measured at 1 and 3 months after intervention |
| Uptake of Voluntary Male Medical Circumcision (VMMC) following HIV self-testing | Proportion of previously uncircumcised participants who self report Voluntary Male Medical Circumcision (VMMC). | measured at 1 and 3 months after intervention |
| Uptake of PrEP by Most-At-Risk Populations (MARP) following HIV self-testing | Proportion of participants considered as Most-At-Risk Populations (MARP) who initiate Pre-exposure prophylaxis (PrEP) | measured at 1 and 3 months after intervention |
| Makerere University |
| Study Director |
| Security companies | Recruiting | Kampala | Uganda |
|
| Muwanguzi PA, Kutyabami P, Osingada CP, Nasuuna EM, Kitutu FE, Ngabirano TD, Nankumbi J, Muhindo R, Kabiri L, Namutebi M, Nabunya R, Kiwanuka N, Sewankambo N. Conducting an ongoing HIV clinical trial during the COVID-19 pandemic in Uganda: a qualitative study of research team and participants' experiences and lessons learnt. BMJ Open. 2021 Apr 21;11(4):e048825. doi: 10.1136/bmjopen-2021-048825. |
| Report on the first international symposium on self-testing for HIV: The legal, ethical, gender, human rights and public health implications of self-testing scale-up | View source |
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |
| D009377 | Multiple Endocrine Neoplasia |
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D009378 | Neoplasms, Multiple Primary |
| D009386 | Neoplastic Syndromes, Hereditary |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D004700 | Endocrine System Diseases |